Developer docs
API playgroundTry for free, no card

Search company profiles

AIROS Medical

Full company profile

uuid0009929

Namestring
AIROS Medical
Legal namestring
AIROS Medical, Inc.
Company typeenum
Private
Founded yearint
2016
Descriptiontext

AIROS Medical, Inc. is a privately-held US medical device company headquartered in Audubon, Pennsylvania, that designs, manufactures, and distributes pneumatic compression therapy systems for the home treatment of lymphatic and vascular disorders. The company was founded in 2016 and currently operates with a small team of 1–10 employees, selling exclusively in the United States through a mix of direct-to-patient e-commerce, a dedicated Durable Medical Equipment (DME) supplier portal, and clinical referrals from lymphedema therapists, vascular specialists, and podiatrists. Its primary end users are patients with lymphedema, chronic venous insufficiency, lipedema, breast cancer-related swelling, and — most recently — peripheral arterial disease (PAD).

The company's product platform centers on multi-chamber pneumatic sequential compression pump systems. The core devices include the AIROS 6 (6-chamber), AIROS 8 (8-chamber, FDA 510(k)-cleared April 2023), and the newer ARTAIRA Arterial Compression Device (launched February 2026, FDA 510(k)-cleared), which uses a two-chamber architecture delivering 120mmHg pressure cycles to increase blood flow to the lower limbs for PAD patients. These pumps are paired with a line of upper extremity, lower extremity, and truncal compression garments (available in 6- and 8-chamber configurations and expanded inclusive sizes). Accessories such as custom travel cases ($74.99) round out the portfolio.

AIROS operates a sales-led, multi-channel go-to-market with a hardware sales revenue model. Products are sold direct-to-consumer via shop.airosmedical.com and indirectly through DME suppliers via dme.airosmedical.com, with Medicare and commercial insurance reimbursement as a critical enabler of patient adoption. Pricing for devices is not publicly disclosed; accessories are unit-priced. The company supports clinical adoption through sponsorship of professional associations (LANA, LSPA, National Lymphedema Network) and patient/advocacy groups, and recently appointed Dr. John N. Evans as Lead Medical Advisor to support ARTAIRA-related clinical and educational initiatives.

Short descriptiontext

AIROS Medical designs and sells FDA-cleared pneumatic compression therapy devices (AIROS 6, AIROS 8, ARTAIRA) and garments used by US patients with lymphedema, venous insufficiency, lipedema, and peripheral arterial disease, distributed via DME suppliers, e-commerce, and clinician referrals with Medicare reimbursement support.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAudubon, United States
HQ citystring
Audubon
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pneumatic compression devices, lymphedema therapy systems, medical compression garments, peripheral arterial disease devices, home sequential compression therapy
Industry3 codes
1Compression Therapy & Lymphedema DME (Garments, Pneumatic Pumps)
CodeHLAHAMAHPrimaryYes
2Compression Therapy for Venous/Lymphedema (Bandages, Wraps, Garments)
CodeHLAHALAFPrimaryNo
3Durable Medical Equipment (DME) Sales & Rentals
CodeHSABAKAAPrimaryNo
NAICS code4 codes
  • Medical Equipment and Supplies Manufacturing3391
  • Surgical Appliance and Supplies Manufacturing339113
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
SIC code4 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Devices / Compression Therapy Equipment
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Compression Therapy Devices
TypeHardware Sales
Description

Sale of pneumatic compression devices (AIROS 6, AIROS 8, ARTAIRA) and associated compression garments (upper extremity, lower extremity, truncal) for home use. Medicare and commercial insurance reimbursement supports patient purchases.

airosmedical.com
2Accessories and Travel Cases
TypeHardware Sales
Description

Sale of accessory products including the ARTAIRA Travel Case ($74.99) designed for safe and convenient device transport for patients, especially during air travel.

prnewswire.com
3DME Supplier Portal
TypeHardware Sales
Description

Business-to-business sales through a dedicated DME Portal (dme.airosmedical.com) where Durable Medical Equipment suppliers can register and access products for distribution to patients.

airosmedical.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Travel Case for compression therapy devices
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$74.99 per travel case, available for purchase directly from the company

prnewswire.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1ARTAIRA
Description

FDA-cleared arterial compression device product line for treating peripheral arterial disease (PAD) symptoms, including rapid high-pressure intermittent compression to increase blood flow to lower limbs.

airosmedical.com
Core offering1 text field

AIROS Medical designs, manufactures, and sells FDA-cleared pneumatic compression therapy devices (AIROS 6, AIROS 8, ARTAIRA) and complementary compression garments for home-based treatment of lymphedema, chronic venous insufficiency, lipedema, and peripheral arterial disease. The company sells through direct-to-patient e-commerce, a dedicated Durable Medical Equipment (DME) supplier portal, and medical professional clinical channels, with Medicare and commercial insurance reimbursement support.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • ARTAIRA device delivers 120mmHg pressure cycles to increase blood flow to lower limbs
+1 more record
Product overview1 text field

AIROS Medical offers a platform of pneumatic compression therapy devices for treating lymphedema, venous insufficiency, lipedema, and peripheral arterial disease. The core product line includes the AIROS 6 and AIROS 8 compression pump devices (with 6 and 8 chambers respectively), paired with a range of compression garments (upper extremity, lower extremity, and truncal garments) that deliver sequential compression therapy. The company expanded into the vascular disorder market with the FDA 510(k)-cleared ARTAIRA Arterial Compression Device for PAD treatment, which delivers higher-pressure 120mmHg cycles. Accessories include custom travel cases for both lymphedema and PAD therapy devices. The portfolio supports patients, medical professionals, and Durable Medical Equipment (DME) suppliers.

Product and service2 records
1AIROS 6
CategoryCompression Therapy Device
Description

Pneumatic sequential compression therapy device for treating lymphedema and venous disorders. Used with upper extremity and lower extremity garments to move lymphatic fluid and improve circulation. Designed for home use by patients with chronic lymphatic and venous conditions.

2AIROS 8
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierMinorTypeOthers
Description

AIROS Medical is a Premier Sponsor of LANA, the Lymphology Association of North America, which is the professional organization for lymphedema therapists. This sponsorship indicates industry recognition and support for professional lymphedema care standards.

Strategic tierMinorTypeOthers
Description

AIROS Medical is associated with the National Lymphedema Network, a nonprofit organization that provides education and guidance to lymphedema patients and healthcare professionals.

Strategic tierMinorTypeOthers
Description

AIROS Medical is associated with Brylan's Feet Foundation, likely a charitable organization supporting patients with lymphatic or compression therapy needs.

Strategic tierMinorTypeOthers
Description

AIROS Medical is a member of LSPA, indicating alignment with professional standards in lymphatic science.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct competitor manufacturing pneumatic compression pumps (VascuEase, Sequential Circulator) for lymphedema, venous insufficiency, and wound care. Sells through the same DME supplier and clinician channels.

TypeEmerging player
Description

Recovery technology brand with pneumatic compression products (RecoveryAir). Sells primarily direct-to-consumer and through wellness channels rather than DME reimbursement, but represents adjacent market pressure.

TypeBroad incumbent
Description

Global incumbent in patient handling, hygiene, and DME including vascular and compression therapy products. Competes with AIROS in clinical compression devices with substantially broader geographic reach.

TypeDirect peer
Description

Direct competitor offering pneumatic compression devices (Circulator Pro) for lymphedema, venous insufficiency, and PAD, distributed via DME suppliers and clinicians in the U.S.

TypeDirect peer
Description

Direct competitor producing sequential pneumatic compression devices (Lympha Press Optimal, Plus) for lymphedema and venous disease, with established DME distribution in the U.S.

TypeEmerging player
Description

Originally a recovery-focused pneumatic compression brand now under Hyperice. Overlaps in the multi-chamber pneumatic compression category but skews toward consumer/wellness rather than insurance-reimbursed DME.

TypeBroad incumbent
Description

Large orthopedic and rehabilitation device incumbent offering compression therapy, recovery, and vascular products through its Chattanooga brand. Competes broadly in the rehab DME category with much deeper distribution.

TypeEmerging player
Description

Neuromodulation and rehabilitation medical device company with overlap in vascular and circulatory therapy adjacencies. Adjacent in clinical rehab channels where lymphedema therapists and vascular specialists practice.

TypeDirect peer
Description

Public company (TMDX) and direct competitor in pneumatic compression therapy for lymphedema and chronic venous insufficiency. Sells the Flexitouch and Entre systems and is the dominant player in the same U.S. DME channel that AIROS targets.

TypeOthers
Description

Major medical products distributor with a U.S. DME and home medical equipment distribution arm. Relevant as a potential channel partner or competitive distribution force for AIROS devices through DME suppliers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AIROS Medical

Medical Devices / Compression Therapy Equipmentairosmedical.com

AIROS Medical designs and sells FDA-cleared pneumatic compression therapy devices (AIROS 6, AIROS 8, ARTAIRA) and garments used by US patients with lymphedema, venous insufficiency, lipedema, and peripheral arterial disease, distributed via DME suppliers, e-commerce, and clinician referrals with Medicare reimbursement support.

What AIROS Medical does

AIROS Medical, Inc. is a privately-held US medical device company headquartered in Audubon, Pennsylvania, that designs, manufactures, and distributes pneumatic compression therapy systems for the home treatment of lymphatic and vascular disorders. The company was founded in 2016 and currently operates with a small team of 1–10 employees, selling exclusively in the United States through a mix of direct-to-patient e-commerce, a dedicated Durable Medical Equipment (DME) supplier portal, and clinical referrals from lymphedema therapists, vascular specialists, and podiatrists. Its primary end users are patients with lymphedema, chronic venous insufficiency, lipedema, breast cancer-related swelling, and — most recently — peripheral arterial disease (PAD).

The company's product platform centers on multi-chamber pneumatic sequential compression pump systems. The core devices include the AIROS 6 (6-chamber), AIROS 8 (8-chamber, FDA 510(k)-cleared April 2023), and the newer ARTAIRA Arterial Compression Device (launched February 2026, FDA 510(k)-cleared), which uses a two-chamber architecture delivering 120mmHg pressure cycles to increase blood flow to the lower limbs for PAD patients. These pumps are paired with a line of upper extremity, lower extremity, and truncal compression garments (available in 6- and 8-chamber configurations and expanded inclusive sizes). Accessories such as custom travel cases ($74.99) round out the portfolio.

AIROS operates a sales-led, multi-channel go-to-market with a hardware sales revenue model. Products are sold direct-to-consumer via shop.airosmedical.com and indirectly through DME suppliers via dme.airosmedical.com, with Medicare and commercial insurance reimbursement as a critical enabler of patient adoption. Pricing for devices is not publicly disclosed; accessories are unit-priced. The company supports clinical adoption through sponsorship of professional associations (LANA, LSPA, National Lymphedema Network) and patient/advocacy groups, and recently appointed Dr. John N. Evans as Lead Medical Advisor to support ARTAIRA-related clinical and educational initiatives.

AIROS Medical firmographics

Firmographics
Name
AIROS Medical
Legal name
AIROS Medical, Inc.
Website
https://airosmedical.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
AIROS Medical designs and sells FDA-cleared pneumatic compression therapy devices (AIROS 6, AIROS 8, ARTAIRA) and garments used by US patients with lymphedema, venous insufficiency, lipedema, and peripheral arterial disease, distributed via DME suppliers, e-commerce, and clinician referrals with Medicare reimbursement support.
Ownership category
akta.pro rank

AIROS Medical industry classification

Industry
Product category
Medical Devices / Compression Therapy Equipment
NAICS
Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Compression Therapy & Lymphedema DME (Garments, Pneumatic Pumps) (HLAHAMAH)
akta.pro secondary industries
Compression Therapy for Venous/Lymphedema (Bandages, Wraps, Garments) (HLAHALAF), Durable Medical Equipment (DME) Sales & Rentals (HSABAKAA)

Keywords

  • Pneumatic compression devices
  • Lymphedema therapy systems
  • Medical compression garments
  • Peripheral arterial disease devices
  • Home sequential compression therapy

Where AIROS Medical is headquartered

Location

Headquarters

HQ city
Audubon
HQ country
United States
HQ region
North America

Offices1 record

Markets served

AIROS Medical business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Compression Therapy Devices: Sale of pneumatic compression devices (AIROS 6, AIROS 8, ARTAIRA) and associated compression garments (upper extremity, lower extremity, truncal) for home use. Medicare and commercial insurance reimbursement supports patient purchases.
  2. Accessories and Travel Cases: Sale of accessory products including the ARTAIRA Travel Case ($74.99) designed for safe and convenient device transport for patients, especially during air travel.
  3. DME Supplier Portal: Business-to-business sales through a dedicated DME Portal (dme.airosmedical.com) where Durable Medical Equipment suppliers can register and access products for distribution to patients.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goTravel Case for compression therapy devices

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

AIROS Medical product offering

Product offering

Core offering

AIROS Medical designs, manufactures, and sells FDA-cleared pneumatic compression therapy devices (AIROS 6, AIROS 8, ARTAIRA) and complementary compression garments for home-based treatment of lymphedema, chronic venous insufficiency, lipedema, and peripheral arterial disease. The company sells through direct-to-patient e-commerce, a dedicated Durable Medical Equipment (DME) supplier portal, and medical professional clinical channels, with Medicare and commercial insurance reimbursement support.

Product overview

AIROS Medical offers a platform of pneumatic compression therapy devices for treating lymphedema, venous insufficiency, lipedema, and peripheral arterial disease. The core product line includes the AIROS 6 and AIROS 8 compression pump devices (with 6 and 8 chambers respectively), paired with a range of compression garments (upper extremity, lower extremity, and truncal garments) that deliver sequential compression therapy. The company expanded into the vascular disorder market with the FDA 510(k)-cleared ARTAIRA Arterial Compression Device for PAD treatment, which delivers higher-pressure 120mmHg cycles. Accessories include custom travel cases for both lymphedema and PAD therapy devices. The portfolio supports patients, medical professionals, and Durable Medical Equipment (DME) suppliers.

Differentiator

Problem solved

Functional benefit

Brands

  • ARTAIRA: FDA-cleared arterial compression device product line for treating peripheral arterial disease (PAD) symptoms, including rapid high-pressure intermittent compression to increase blood flow to lower limbs.

Products and services

  • AIROS 6 Pneumatic sequential compression therapy device for treating lymphedema and venous disorders. Used with upper extremity and lower extremity garments to move lymphatic fluid and improve circulation. Designed for home use by patients with chronic lymphatic and venous conditions.
  • AIROS 8

Quantifiable outcome

  • ARTAIRA device delivers 120mmHg pressure cycles to increase blood flow to lower limbs
  • +1 more outcomes

Companies that use AIROS Medical

Customer profile

Segments4 records

Ideal customer profiles3 records

AIROS Medical technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

AIROS Medical partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered minor.

  • LANA (Lymphology Association of North America)minorOthersAIROS Medical is a Premier Sponsor of LANA, the Lymphology Association of North America, which is the professional organization for lymphedema therapists. This sponsorship indicates industry recognition and support for professional lymphedema care standards.
  • National Lymphedema NetworkminorOthersAIROS Medical is associated with the National Lymphedema Network, a nonprofit organization that provides education and guidance to lymphedema patients and healthcare professionals.
  • Brylan's Feet FoundationminorOthersAIROS Medical is associated with Brylan's Feet Foundation, likely a charitable organization supporting patients with lymphatic or compression therapy needs.
  • LSPA (Lymphatic Science Professionals Association)minorOthersAIROS Medical is a member of LSPA, indicating alignment with professional standards in lymphatic science.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

AIROS Medical competitors and assessment

Company assessment

Direct peers

  • Bio Compression Systems: Direct competitor manufacturing pneumatic compression pumps (VascuEase, Sequential Circulator) for lymphedema, venous insufficiency, and wound care. Sells through the same DME supplier and clinician channels.
  • Devon Medical Products: Direct competitor offering pneumatic compression devices (Circulator Pro) for lymphedema, venous insufficiency, and PAD, distributed via DME suppliers and clinicians in the U.S.
  • Lympha Press (Mego Afek): Direct competitor producing sequential pneumatic compression devices (Lympha Press Optimal, Plus) for lymphedema and venous disease, with established DME distribution in the U.S.
  • Tactile Medical: Public company (TMDX) and direct competitor in pneumatic compression therapy for lymphedema and chronic venous insufficiency. Sells the Flexitouch and Entre systems and is the dominant player in the same U.S. DME channel that AIROS targets.

Emerging players

  • Therabody: Recovery technology brand with pneumatic compression products (RecoveryAir). Sells primarily direct-to-consumer and through wellness channels rather than DME reimbursement, but represents adjacent market pressure.
  • NormaTec (Hyperice): Originally a recovery-focused pneumatic compression brand now under Hyperice. Overlaps in the multi-chamber pneumatic compression category but skews toward consumer/wellness rather than insurance-reimbursed DME.
  • Bioness: Neuromodulation and rehabilitation medical device company with overlap in vascular and circulatory therapy adjacencies. Adjacent in clinical rehab channels where lymphedema therapists and vascular specialists practice.

Broad incumbents

  • Arjo (Huntleigh Healthcare): Global incumbent in patient handling, hygiene, and DME including vascular and compression therapy products. Competes with AIROS in clinical compression devices with substantially broader geographic reach.
  • Enovis (DJO Global / Chattanooga): Large orthopedic and rehabilitation device incumbent offering compression therapy, recovery, and vascular products through its Chattanooga brand. Competes broadly in the rehab DME category with much deeper distribution.

Others

  • Cardinal Health (Medical / At-Home Solutions): Major medical products distributor with a U.S. DME and home medical equipment distribution arm. Relevant as a potential channel partner or competitive distribution force for AIROS devices through DME suppliers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

AIROS Medical social profiles

Digital presence

AIROS Medical compliance and trust

Trust signal

Compliance2 records

AIROS Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AIROS Medical leadership team

Management profile

Number of profiles

Profiles3 records

AIROS Medical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AIROS Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AIROS Medical

What does AIROS Medical do?

AIROS Medical designs, manufactures, and sells FDA-cleared pneumatic compression therapy devices (AIROS 6, AIROS 8, ARTAIRA) and complementary compression garments for home-based treatment of lymphedema, chronic venous insufficiency, lipedema, and peripheral arterial disease. The company sells through direct-to-patient e-commerce, a dedicated Durable Medical Equipment (DME) supplier portal, and medical professional clinical channels, with Medicare and commercial insurance reimbursement support.

Is AIROS Medical a public or private company?

AIROS Medical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was AIROS Medical founded?

AIROS Medical was founded in 2016. It employs 1 to 10 people.

Where is AIROS Medical based?

AIROS Medical is headquartered in Audubon, United States, in the North America region.

How does AIROS Medical make money?

Three revenue lines are on record. Compression Therapy Devices are the primary driver. The others are accessories and Travel Cases and DME Supplier Portal.

Who are AIROS Medical's main competitors?

Direct peers on record are Bio Compression Systems, Devon Medical Products, Lympha Press (Mego Afek) and Tactile Medical. Emerging players are Therabody, NormaTec (Hyperice) and Bioness. Broad incumbents are Arjo (Huntleigh Healthcare) and Enovis (DJO Global / Chattanooga). Cardinal Health (Medical / At-Home Solutions) is listed as an others.

Does AIROS Medical have an API?

No public API is recorded for AIROS Medical.

What industry is AIROS Medical in?

AIROS Medical's product category is Medical Devices / Compression Therapy Equipment. Its primary akta.pro industry code is HLAHAMAH, Compression Therapy & Lymphedema DME (Garments, Pneumatic Pumps), with a secondary code of HLAHALAF, Compression Therapy for Venous/Lymphedema (Bandages, Wraps, Garments). Its NAICS code is 3391 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MedicalEconomicsAIROS Medical launches FDA-cleared home compression device for peripheral arterial diseaseAIROS Medical Inc. has launched the ARTAIRA Arterial Compression Device, an FDA 510(k)-cleared intermittent pneumatic compression system for home use by patients with peripheral arterial disease. The device delivers 120 mmHg of pressure to the calf, ankle, and foot through a two-chamber garment system to improve circulation and help prevent serious complications including amputation. ARTAIRA is now available nationwide and is covered by Medicare and qualifying commercial insurance plans.PR NewswireAIROS Medical Introduces ARTAIRA Travel Case to Support Therapy Continuity for PAD PatientsAIROS Medical, a medical technology manufacturer specializing in compression therapy systems, announced the availability of the ARTAIRA Travel Case on May 6, 2026, an accessory designed to help patients with peripheral arterial disease safely transport their ARTAIRA Arterial Compression Device while traveling or during daily activities. The company received FDA 510(k) clearance for the ARTAIRA device earlier this year, and the $74.99 travel case features protective padding, organized storage compartments, and is designed to support patient compliance with prescribed compression therapy routines.openPR.comCompetitive Analysis: Leading Companies and New Entrants in the Home Sequential Compression Devices MarketThe home sequential compression devices market is projected to grow to $1.62 billion by 2030 with a compound annual growth rate of 6.5%, driven by rising demand for connected home medical equipment, remote patient monitoring, and wearable medical technologies. In December 2024, SHS Capital, a German private equity firm, acquired a majority stake in Medizintechnik Rostock GmbH to support its succession planning and drive nationwide expansion of homecare therapies in Germany. Additionally, AIROS Medical Inc. launched its AIROS 6P sequential compression device and compression pants in September 2023, reflecting ongoing product innovation in the sector.PR NewswireAIROS Medical Appoints Dr. John Evans as Lead Medical AdvisorAIROS Medical, Inc., a Pennsylvania-based medical technology manufacturer specializing in compression therapy systems, announced the appointment of Dr. John N. Evans as Lead Medical Advisor effective March 31, 2026. Dr. Evans, a board-certified podiatric surgeon with over 20 years of experience in peripheral arterial disease treatment, will lead physician education and clinical engagement initiatives for the company's ARTAIRA Arterial Compression Device, including conference lectures, workshops, and webinars. The FDA-cleared ARTAIRA device is available throughout the United States and is reimbursed by Medicare and select commercial insurers.PR NewswireAIROS Medical Launches ARTAIRA Compression Device to Treat Patients with Symptoms of Peripheral Arterial Disease (PAD)AIROS Medical, Inc. announced on February 4, 2026 the U.S. launch of its FDA 510(k)-cleared ARTAIRA Arterial Compression Device, a non-invasive pneumatic compression therapy for treating symptoms of peripheral arterial disease (PAD) in patients' homes. The two-chamber device delivers 120mmHg pressure cycles to increase blood flow to the legs, feet, and toes, and is now available throughout the United States with Medicare and commercial insurance reimbursement. The launch expands the company's compression therapy portfolio from lymphedema and venous insufficiency treatment into the vascular disorder market, addressing a condition projected to affect over 360 million people globally by 2050.FortunebusinessinsightsHome Sequential Compression Devices Market Size, Report, 2034The global home sequential compression devices market is projected to grow during 2021–2034, driven by increasing prevalence of venous and lymphatic disorders such as deep vein thrombosis (DVT), lymphedema, and chronic venous insufficiency (CVI), along with rising awareness of circulatory health and improved device portability. North America is expected to hold a significant market share, while the Asia Pacific region is projected to grow at a notable CAGR due to rising diabetes prevalence and demand for non-invasive treatments. Key industry developments include AIROS Medical's FDA 510(k) clearance for its AIROS 8P device in April 2023 and KOYA MEDICAL's launch of the Dayspring active compression system in April 2022.PR NewswireAIROS Medical Announces Five-Year Warranty on Lymphedema Pneumatic Compression DevicesAIROS Medical announced a five-year warranty for its pneumatic sequential compression devices, expanding from the previous three-year warranty. The devices are used to treat lymphedema and venous disorders, supporting patients and healthcare providers. The change underscores the company's confidence in device durability and its commitment to quality.PharmiWeb.comCompression Therapy Market Set for Steady Growth with Advanced Precision Solutions: Forecast 2025-2030The global compression therapy market is projected to grow at approximately 5% CAGR over 2025-2030, driven by rising prevalence of venous and lymphatic disorders, an aging population, and advancements in compression technologies. Recent industry developments include Tactile Medical's expanded U.S. rollout of its next-generation Nimbl pneumatic compression platform for lower extremity conditions (February 2025), Cardinal Health's launch of the Kendall SCD smart compression system for VTE prevention (November 2024), and Airos Medical's introduction of the AIROS 6P sequential pneumatic compression device (September 2023).PR NewswireAIROS Medical Launches Expanded Truncal Compression Garment Line, Offering Greater Inclusivity for Lymphedema PatientsAIROS Medical announced the launch of expanded sizing for its truncal compression garments, adding six new 8-chamber models in varying inseam lengths and abdominal circumferences to treat lymphedema patients with abdominal and pelvic swelling. The garments are designed for use with the AIROS 8P pneumatic compression device and are reimbursed by Medicare and commercial insurance nationwide. The new models aim to provide more inclusive, non-custom treatment options for the millions of Americans living with lymphedema.